These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24164913)

  • 41. The relationship between serum osteopontin and FGF 23 levels with valvular calcification in hemodialysis patients
.
    Ganidagli B; Nacar H; Yildiz YS; Dagli H; Erken E; Altunoren O; Gungor O
    Clin Nephrol; 2019 Jan; 91(1):9-16. PubMed ID: 30369401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations of Cognitive Function and Education Level With All-Cause Mortality in Adults on Hemodialysis: Findings From the COGNITIVE-HD Study.
    van Zwieten A; Wong G; Ruospo M; Palmer SC; Teixeira-Pinto A; Barulli MR; Iurillo A; Saglimbene V; Natale P; Gargano L; Murgo M; Loy CT; Tortelli R; Craig JC; Johnson DW; Tonelli M; Hegbrant J; Wollheim C; Logroscino G; Strippoli GFM;
    Am J Kidney Dis; 2019 Oct; 74(4):452-462. PubMed ID: 31160141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis.
    Kojima F; Uchida K; Ogawa T; Tanaka Y; Nitta K
    Int Urol Nephrol; 2008; 40(4):1067-74. PubMed ID: 18791804
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction.
    Nielsen TL; Plesner LL; Warming PE; Mortensen OH; Iversen KK; Heaf JG
    Nefrologia (Engl Ed); 2019; 39(3):258-268. PubMed ID: 30723045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Depression and cognitive function in maintenance hemodialysis patients.
    Agganis BT; Weiner DE; Giang LM; Scott T; Tighiouart H; Griffith JL; Sarnak MJ
    Am J Kidney Dis; 2010 Oct; 56(4):704-12. PubMed ID: 20673602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association Between Risk Factors Including Bone-Derived Biomarkers and Aortic Arch Calcification in Maintenance Hemodialysis Patients.
    Nitta K; Hanafusa N; Okazaki M; Komatsu M; Kawaguchi H; Tsuchiya K
    Kidney Blood Press Res; 2018; 43(5):1554-1562. PubMed ID: 30347400
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The value of serum FGF-23 as a cardiovascular marker in HD patients.
    Sany D; Elsawy AE; Aziz A; Elshahawy Y; Ahmed H; Aref H; El Rahman MA
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):44-52. PubMed ID: 24434381
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fibroblast growth factor-23 and cardiovascular events in CKD.
    Scialla JJ; Xie H; Rahman M; Anderson AH; Isakova T; Ojo A; Zhang X; Nessel L; Hamano T; Grunwald JE; Raj DS; Yang W; He J; Lash JP; Go AS; Kusek JW; Feldman H; Wolf M;
    J Am Soc Nephrol; 2014 Feb; 25(2):349-60. PubMed ID: 24158986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].
    Milovanova LY; Kozlovskaya LV; Markina MM; Milovanova SY; Borisov AA; Mukhin NA; Fomin VV; Moiseev SV
    Klin Med (Mosk); 2015; 93(12):32-8. PubMed ID: 27149811
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis.
    Humalda JK; Riphagen IJ; Assa S; Hummel YM; Westerhuis R; Vervloet MG; Voors AA; Navis G; Franssen CF; de Borst MH;
    Nephrol Dial Transplant; 2016 Sep; 31(9):1494-501. PubMed ID: 26602863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relation of fibroblast growth factor-23 and cardiovascular calcification in end-stage kidney disease patients on regular hemodialysis.
    El Baz TZ; Khamis OA; Ahmed Gheith OA; Abd Ellateif SS; Abdallah AM; Abd El Aal HC
    Saudi J Kidney Dis Transpl; 2017; 28(1):51-60. PubMed ID: 28098103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast growth factor 23 and cognitive impairment: The health, aging, and body composition study.
    Drew DA; Katz R; Kritchevsky S; Ix JH; Shlipak M; Newman AB; Hoofnagle A; Fried L; Gutiérrez OM; Sarnak M
    PLoS One; 2020; 15(12):e0243872. PubMed ID: 33306729
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased presence of cognitive impairment in hemodialysis patients in the absence of neurological events.
    Post JB; Morin KG; Sano M; Jegede AB; Langhoff E; Spungen AM
    Am J Nephrol; 2012; 35(2):120-6. PubMed ID: 22212437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fibroblast growth factor-23 and interleukin-6 are risk factors for left ventricular hypertrophy in peritoneal dialysis patients.
    Liu WH; Zhou QL; Ao X; Yu HL; Peng WS; He N
    J Cardiovasc Med (Hagerstown); 2012 Sep; 13(9):565-9. PubMed ID: 22728833
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis.
    O'Lone E; Connors M; Masson P; Wu S; Kelly PJ; Gillespie D; Parker D; Whiteley W; Strippoli GF; Palmer SC; Craig JC; Webster AC
    Am J Kidney Dis; 2016 Jun; 67(6):925-35. PubMed ID: 26919914
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cognitive function and dialysis adequacy: no clear relationship.
    Giang LM; Weiner DE; Agganis BT; Scott T; Sorensen EP; Tighiouart H; Sarnak MJ
    Am J Nephrol; 2011; 33(1):33-8. PubMed ID: 21150193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.
    Montford JR; Chonchol M; Cheung AK; Kaufman JS; Greene T; Roberts WL; Smits G; Kendrick J;
    Am J Nephrol; 2013; 37(3):183-90. PubMed ID: 23428834
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
    Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
    JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FGF-23 and the progression of coronary arterial calcification in patients new to dialysis.
    Khan AM; Chirinos JA; Litt H; Yang W; Rosas SE
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):2017-22. PubMed ID: 22997345
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification.
    Fu X; Cui QQ; Ning JP; Fu SS; Liao XH
    Med Sci Monit; 2015 Nov; 21():3467-73. PubMed ID: 26558428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.